These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 6998487)

  • 21. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
    Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
    Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
    [No Abstract]   [Full Text] [Related]  

  • 22. The antihypertensive effect of guanfacine compared with methyldopa.
    van der Merwe CJ; Kruger SA
    S Afr Med J; 1980 Mar; 57(11):400-4. PubMed ID: 6105713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive therapy with guanfacine induces elevated plasma growth hormone levels in diabetic patients.
    Coves MJ; Gomis R; Casamitjana R; Lienas V; Vilaradell E
    J Med; 1989; 20(3-4):291-6. PubMed ID: 2572660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guanfacine for hypertension.
    Med Lett Drugs Ther; 1987 May; 29(740):49-50. PubMed ID: 2883560
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical dose-response studies with guanfacine (BS 100-141), a new antihypertensive agent.
    MacCarthy P; Isaac P; Frost G; Freeman A; Stokes G
    Clin Exp Pharmacol Physiol; 1978; 5(2):187-90. PubMed ID: 348364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of arterial hypertension with a single daily dose of guanfacine].
    Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
    Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypotensive effect of guanfacine in essential hypertension: a comparison with clonidine.
    Lauro R; Reda G; Spallone L; Anguissola AB
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):81S-82S. PubMed ID: 6994784
    [No Abstract]   [Full Text] [Related]  

  • 28. Antihypertensive effects and plasma levels of guanfacine in man.
    Safar ME; Loria Y; Weiss YA; Boutier JR
    J Clin Pharmacol; 1982; 22(8-9):385-90. PubMed ID: 6752213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin, renin, growth hormone, lipoproteins and glucose under guanfacine treatment.
    Hauger-Klevene JH; Balossi EC; Scornavacchi JC
    Cor Vasa; 1987; 29(4 Suppl 1):17-22. PubMed ID: 3119290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term antihypertensive therapy with guanfacine.
    Szám I; Holló J
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):388-92. PubMed ID: 6749702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive monitoring of ambulatory blood pressure and its variability in elderly hypertensive patients: effect of guanfacine.
    Dupont AG; Vanderniepen P; Six RO
    Bibl Cardiol; 1987; (42):161-7. PubMed ID: 3307757
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hypotensive and hemodynamic effects of guanfacine in arterial hypertension].
    Erina EV; Beliakova EV; Charyev KhZ; Panfilov VV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(1):63-7. PubMed ID: 2663029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The centrally acting antihypertensive drug guanfacine. Effect on lung function and circulatory parameters in hypertensive patients with bronchial asthma].
    Dorow P; Knaup G
    ZFA (Stuttgart); 1983 Sep; 59(27):1520-4. PubMed ID: 6359750
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antihypertensive effectiveness of a guanfacine/clopamide combination].
    Wetzels E; Weidinger G
    MMW Munch Med Wochenschr; 1982 Oct; 124(40):871-4. PubMed ID: 6815503
    [No Abstract]   [Full Text] [Related]  

  • 35. Duration of the hypotensive effect of guanfacine.
    Magometschnigg D; Bonelli J; Gassner A; Hitzenberger G; Lenzhofer R; Kleinberger G; Pall H
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):174-8. PubMed ID: 7042594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Minimal useful dose of guanfacine in patients with essential hypertension].
    Pérez Olea J; Ortíz N; Soledad Bertoló M; Allel L; Goity C; Quevedo M
    Rev Med Chil; 1985 May; 113(5):420-4. PubMed ID: 3912882
    [No Abstract]   [Full Text] [Related]  

  • 37. Antihypertensive effect of guanfacine: a double-blind cross-over trial compared with clonidine.
    Distler A; Kirch W; Lüth B
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):49S-53S. PubMed ID: 6994778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of two antihypertensive agents: guanfacine and guanethidine.
    Szám I; Kállay K
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz).
    Bazika V
    Cor Vasa; 1987; 29(4 Suppl 1):42-5. PubMed ID: 3315450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Improvement of the functional capacity of hypertensive patients treated with guanfacine].
    Bazika V; Neuzil P; Tiserová J; Hrabovský F
    Cas Lek Cesk; 1986 May; 125(21):637-40. PubMed ID: 3518943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.